Cargando…

Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia

BACKGROUND: Australian harm reduction services are provided via a mix of modalities, including fixed-site needle and syringe programmes (NSP) and syringe-dispensing machines (SDMs). SDMs are cost-effective and provide 24-h anonymous access to needles/syringes, often to underserved geographic areas,...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Keefe, Daniel, Livingston, Michael, Cossar, Reece D., Kerr, Phoebe, Jacka, David, Dietze, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449958/
https://www.ncbi.nlm.nih.gov/pubmed/36071500
http://dx.doi.org/10.1186/s12954-022-00683-9
_version_ 1784784417497022464
author O’Keefe, Daniel
Livingston, Michael
Cossar, Reece D.
Kerr, Phoebe
Jacka, David
Dietze, Paul
author_facet O’Keefe, Daniel
Livingston, Michael
Cossar, Reece D.
Kerr, Phoebe
Jacka, David
Dietze, Paul
author_sort O’Keefe, Daniel
collection PubMed
description BACKGROUND: Australian harm reduction services are provided via a mix of modalities, including fixed-site needle and syringe programmes (NSP) and syringe-dispensing machines (SDMs). SDMs are cost-effective and provide 24-h anonymous access to needles/syringes, often to underserved geographic areas, and can attract clientele who may choose not to use NSPs. The introduction of COVID-19 control measures saw disruptions and adaptations to the provision of harm reduction services. It is possible that SDMs filled the gap in otherwise disrupted harm reduction services in Melbourne. In this paper, we use data from four SDMs and an NSP to explore changes to harm reduction usage during periods of COVID-19 lockdowns in Melbourne, Australia, in 2020. METHODS: Our data span September 2017–December 2020. We analysed daily counts of SDM use and monthly counts of NSP use, according to unique presentations to both. Auto-regressive integrated moving average (ARIMA) time-series models were fitted to the data with the effects of lockdowns estimated via a step function. RESULTS: Across the study period, we estimated 85,851 SDM presentations and 29,051 NSP presentations. Usage across both the SDMs and the NSP declined during the COVID-19 lockdowns, but only the decline in SDM usage was significant in ARIMA analysis. CONCLUSIONS: The slight, but significant decline in SDM use suggests barriers to access, though this may have been mitigated by SDM users acquiring needles/syringes from other sources. The decline, however, may be a concern if it led to lowered needle/syringe coverage and a subsequent increase in injecting risk. Further work is needed to properly explore potential changes in preference for needle/syringe acquisition site and associated barriers. Importantly, this work adds to the body of literature around the impacts of COVID-19 on harm reduction provision and potential areas of improvement.
format Online
Article
Text
id pubmed-9449958
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94499582022-09-07 Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia O’Keefe, Daniel Livingston, Michael Cossar, Reece D. Kerr, Phoebe Jacka, David Dietze, Paul Harm Reduct J Brief Report BACKGROUND: Australian harm reduction services are provided via a mix of modalities, including fixed-site needle and syringe programmes (NSP) and syringe-dispensing machines (SDMs). SDMs are cost-effective and provide 24-h anonymous access to needles/syringes, often to underserved geographic areas, and can attract clientele who may choose not to use NSPs. The introduction of COVID-19 control measures saw disruptions and adaptations to the provision of harm reduction services. It is possible that SDMs filled the gap in otherwise disrupted harm reduction services in Melbourne. In this paper, we use data from four SDMs and an NSP to explore changes to harm reduction usage during periods of COVID-19 lockdowns in Melbourne, Australia, in 2020. METHODS: Our data span September 2017–December 2020. We analysed daily counts of SDM use and monthly counts of NSP use, according to unique presentations to both. Auto-regressive integrated moving average (ARIMA) time-series models were fitted to the data with the effects of lockdowns estimated via a step function. RESULTS: Across the study period, we estimated 85,851 SDM presentations and 29,051 NSP presentations. Usage across both the SDMs and the NSP declined during the COVID-19 lockdowns, but only the decline in SDM usage was significant in ARIMA analysis. CONCLUSIONS: The slight, but significant decline in SDM use suggests barriers to access, though this may have been mitigated by SDM users acquiring needles/syringes from other sources. The decline, however, may be a concern if it led to lowered needle/syringe coverage and a subsequent increase in injecting risk. Further work is needed to properly explore potential changes in preference for needle/syringe acquisition site and associated barriers. Importantly, this work adds to the body of literature around the impacts of COVID-19 on harm reduction provision and potential areas of improvement. BioMed Central 2022-09-07 /pmc/articles/PMC9449958/ /pubmed/36071500 http://dx.doi.org/10.1186/s12954-022-00683-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Brief Report
O’Keefe, Daniel
Livingston, Michael
Cossar, Reece D.
Kerr, Phoebe
Jacka, David
Dietze, Paul
Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia
title Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia
title_full Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia
title_fullStr Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia
title_full_unstemmed Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia
title_short Time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during COVID-19 lockdowns in Melbourne, Australia
title_sort time-series analysis of presentations to four syringe dispensing machines and a needle and syringe programme during covid-19 lockdowns in melbourne, australia
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449958/
https://www.ncbi.nlm.nih.gov/pubmed/36071500
http://dx.doi.org/10.1186/s12954-022-00683-9
work_keys_str_mv AT okeefedaniel timeseriesanalysisofpresentationstofoursyringedispensingmachinesandaneedleandsyringeprogrammeduringcovid19lockdownsinmelbourneaustralia
AT livingstonmichael timeseriesanalysisofpresentationstofoursyringedispensingmachinesandaneedleandsyringeprogrammeduringcovid19lockdownsinmelbourneaustralia
AT cossarreeced timeseriesanalysisofpresentationstofoursyringedispensingmachinesandaneedleandsyringeprogrammeduringcovid19lockdownsinmelbourneaustralia
AT kerrphoebe timeseriesanalysisofpresentationstofoursyringedispensingmachinesandaneedleandsyringeprogrammeduringcovid19lockdownsinmelbourneaustralia
AT jackadavid timeseriesanalysisofpresentationstofoursyringedispensingmachinesandaneedleandsyringeprogrammeduringcovid19lockdownsinmelbourneaustralia
AT dietzepaul timeseriesanalysisofpresentationstofoursyringedispensingmachinesandaneedleandsyringeprogrammeduringcovid19lockdownsinmelbourneaustralia